It looks like market sentiment is well and truly off Judith and the management of this company. Great products base but a hopeless leadership team.
I am a bit concerned that they have stopped giving us the update as to the hospital and surgeon uptakes of Xperience in the US in the latest Q4 presentation like they did in the half yearly. Did anyone find any information on how this is tracking?
Ann: Appendix 4C - 31 December 2022, page-9
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $7.298K | 36.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2090 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 7938 | 2 |
View Market Depth
| Last trade - 10.41am 27/09/2024 (20 minute delay) ? |
| NXS (ASX) Chart |